论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

TGF-β1/Smad信号通路在肝纤维化中的作用机制及中医药调控研究进展OACSTPCD

Research Progress on Action Mechanism of TGF-β1/Smad Signaling Pathway in Liver Fibrosis and TCM Regulation

中文摘要英文摘要

转化生长因子(transforming growth factor-β,TGF-β1)/Smad信号通路传导途径及其调控的相关蛋白与肝纤维化的发生发展密切相关.中医药抗肝纤维化作用显著,黄酮类、萜类、皂苷类、酚酸类、多糖类等多种中药有效成分均可通过调节TGF-β1/Smad信号通路抑制肝星状细胞(hepatic stellate cells,HSC)增殖活化及细胞外基质(extracellular matrix,ECM)合成,减少胶原蛋白沉积,改善肝功能,降低肝组织炎症浸润水平.目前,中医药治疗肝纤维化仍存在一些局限性,如体外细胞实验较少;中药复方抗肝纤维化具体发挥作用的成分尚未明确,且多途径间的协同作用亟须关注;相关研究多为基础实验,缺乏双盲、多中心、随机对照的临床试验研究.今后亦可将调控分子信号通路与中医辨证施治相结合,组合而成新的方药,为抗肝纤维化新药的研发提供一定的思路.

Transforming growth factor-β(TGF-β1).The signaling pathway and related proteins regulated by Smad are closely related to the occurrence and development of liver fibrosis.Traditional Chinese medicine has a significant anti liver fibrosis effect,and various effective components of traditional Chinese medicine,such as flavonoids,terpenoids,saponins,phenolic acids,and polysaccharides,can all pass through TGF-β1/Smad signaling pathway protein expression inhibits the proliferation and activation of hepatic stellate cells(HSCs)and the synthesis of extracellular matrix(ECM),reduces collagen deposition,improves liver function,and reduces the level of inflammatory infiltration in liver tissue.At present,there are still some limitations in the treatment of liver fibrosis with traditional Chi-nese medicine,such as limited in vitro cell experiments;The specific components of the anti liver fibrosis effect of traditional Chinese medicine compound are not yet clear,and the synergistic effects between multiple pathways urgently need to be paid attention to;The relevant research is mostly based on basic experiments,lacking double blind,multi-center,and randomized controlled clinical studies.In the future,the regulation of molecular signaling pathways can also be combined with traditional Chinese medicine syndrome differenti-ation and treatment to form new prescriptions,providing a certain idea for the development of new drugs against liver fibrosis.

和梦静;赵长普;胡慧慧;王菲;郝晨源

河南中医药大学第二临床医学院,河南 郑州 450002河南中医药大学第二附属医院/河南省中医院,河南 郑州 450002

中医学

肝纤维化;TGF-β1/Smad;中药;抗纤维化

liver fibrosis;TGF-β1/Smad;traditional Chinese medicine;anti-fibrosis

《中医学报》 2024 (001)

114-121 / 8

河南省中医药科学研究专项课题项目(2022ZY1068);2022年度河南省高等学校重点科研项目(22A360014)

10.16368/j.issn.1674-8999.2024.01.019

评论

下载量:0
点击量:0